Lini Chen

1.3k total citations · 2 hit papers
19 papers, 939 citations indexed

About

Lini Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lini Chen has authored 19 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Lini Chen's work include Epigenetics and DNA Methylation (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Ferroptosis and cancer prognosis (3 papers). Lini Chen is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Ferroptosis and cancer prognosis (3 papers). Lini Chen collaborates with scholars based in China, United States and Thailand. Lini Chen's co-authors include Linbo Wang, Zhaoqing Li, Cong Chen, Jichun Zhou, Misha Mao, Yongxia Chen, Jingjing Yang, Yonggang Lv, Xun Zhang and Yulu Zhou and has published in prestigious journals such as ACS Sustainable Chemistry & Engineering, The Analyst and Cell Death and Disease.

In The Last Decade

Lini Chen

19 papers receiving 936 citations

Hit Papers

Metformin induces Ferroptosis by inhibiting UFMylation of... 2021 2026 2022 2024 2021 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lini Chen China 11 574 386 377 162 105 19 939
Yang Kong China 13 516 0.9× 321 0.8× 234 0.6× 105 0.6× 80 0.8× 37 804
Lijie Chen China 18 484 0.8× 255 0.7× 291 0.8× 259 1.6× 118 1.1× 49 1.0k
Ge Gao China 10 434 0.8× 293 0.8× 375 1.0× 68 0.4× 81 0.8× 26 741
Xian‐Lu Song China 13 492 0.9× 287 0.7× 159 0.4× 122 0.8× 67 0.6× 22 765
Lingqun Ye China 15 605 1.1× 422 1.1× 356 0.9× 255 1.6× 93 0.9× 30 1.2k
Yangjia Zhuo China 16 436 0.8× 282 0.7× 185 0.5× 92 0.6× 47 0.4× 44 674
Sheng Zhou China 24 586 1.0× 239 0.6× 190 0.5× 372 2.3× 106 1.0× 46 1.1k
Simon Schwörer United States 9 502 0.9× 268 0.7× 127 0.3× 148 0.9× 69 0.7× 9 794

Countries citing papers authored by Lini Chen

Since Specialization
Citations

This map shows the geographic impact of Lini Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lini Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lini Chen more than expected).

Fields of papers citing papers by Lini Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lini Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lini Chen. The network helps show where Lini Chen may publish in the future.

Co-authorship network of co-authors of Lini Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lini Chen. A scholar is included among the top collaborators of Lini Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lini Chen. Lini Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Lini, Diandian Liu, Weicong Hong, et al.. (2025). Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin. Human Gene Therapy. 36(7-8). 765–773. 1 indexed citations
2.
Feng, Lifeng, Lini Chen, Weikai Wang, et al.. (2024). PRMT6-mediated ADMA promotes p62 phase separation to form a negative feedback loop in ferroptosis. Theranostics. 14(10). 4090–4106. 2 indexed citations
3.
Chen, Lini, et al.. (2024). Effect of Remimazolam on Induction and Maintenance of General Anesthesia in Kidney Transplant Patients. International Journal of General Medicine. Volume 17. 2455–2463. 2 indexed citations
4.
Chen, Lini, et al.. (2023). The Effect of Different Doses of Ciprofol in Patients with Painless Gastrointestinal Endoscopy. Drug Design Development and Therapy. Volume 17. 1733–1740. 28 indexed citations
5.
Chen, Jida, Lini Chen, Zilong Bian, et al.. (2023). Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study. Cancer Treatment and Research Communications. 36. 100719–100719. 2 indexed citations
6.
Chen, Cong, Bojian Xie, Zhaoqing Li, et al.. (2022). Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis. Cell Death and Disease. 13(2). 44 indexed citations
7.
Hu, Dengdi, Zhaoqing Li, Bin Zheng, et al.. (2022). Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities. Cancer Communications. 42(5). 401–434. 174 indexed citations breakdown →
8.
Chen, Yongxia, Yunlu Jia, Misha Mao, et al.. (2021). PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer. Journal of Cellular and Molecular Medicine. 25(14). 6948–6962. 20 indexed citations
9.
Yang, Jingjing, Yulu Zhou, Shuduo Xie, et al.. (2021). Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 206–206. 270 indexed citations breakdown →
10.
Lv, Yonggang, Xiaomei Zhang, & Lini Chen. (2021). Suspension state regulates epithelial-to-mesenchymal transition and stemness of breast tumor cells. Biotechnology Letters. 43(3). 561–578. 4 indexed citations
11.
Xu, Ling, Lijie Chen, Jida Chen, et al.. (2021). Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine. Frontiers in Cell and Developmental Biology. 9. 744990–744990. 13 indexed citations
12.
Li, Zhaoqing, Wenying Zhuo, Lini Chen, et al.. (2021). Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient. Frontiers in Cell and Developmental Biology. 9. 680968–680968. 3 indexed citations
13.
Chen, Lini, et al.. (2020). RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA. Theranostics. 10(7). 3190–3205. 109 indexed citations
14.
Wang, Qinchuan, Xiyong Liu, Chen Chen, et al.. (2020). A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer. Translational Oncology. 14(1). 100901–100901. 10 indexed citations
15.
Li, Zhaoqing, Lini Chen, Cong Chen, et al.. (2020). Targeting ferroptosis in breast cancer. Biomarker Research. 8(1). 58–58. 150 indexed citations
16.
Mao, Misha, Yongxia Chen, Yunlu Jia, et al.. (2019). PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF‐κB pathway. Journal of Cellular and Molecular Medicine. 23(10). 6930–6941. 31 indexed citations
17.
Chen, Lini, et al.. (2017). HCoM: Item-Based Similarity Model for Heterogeneous Implicit Feedback. 72. 40–49. 3 indexed citations
18.
Su, Yubin, et al.. (2016). Silver Nanoparticles/N-Doped Carbon-Dots Nanocomposites Derived from Siraitia Grosvenorii and Its Logic Gate and Surface-Enhanced Raman Scattering Characteristics. ACS Sustainable Chemistry & Engineering. 4(3). 1728–1735. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026